Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
LY5-H52H3 | Human | Human LY75 / CD205 Protein, His Tag | ![]() |
![]() ![]() |
|
LY5-M52H5 | Mouse | Mouse LY75 / CD205 Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Rasdegafusp alfa | CDX-1401 | Phase 2 Clinical | Ludwig Institute For Cancer Research | Sarcoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Carcinoma, Endometrioid; Melanoma; Leukemia, Myeloid, Acute; Fallopian Tube Neoplasms; Lung Neoplasms; Endometrial Neoplasms; Uterine Neoplasms; Peritoneal Neoplasms; Astrocytoma; Colorectal Neoplasms; Brain Neoplasms; Prostatic Neoplasms; Breast Neoplasms; Skin Melanoma; Uveal melanoma; Oligodendroglioma; Urinary Bladder Neoplasms; Hormone-Resistant Prostate Neoplasms; Carcinoma, Ovarian Epithelial; Neoplasms; Anemia, Refractory; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Colonic Neoplasms; Glioblastoma; Stomach Neoplasms; Carcinoma, Renal Cell; Esophageal Neoplasms; Ovarian Neoplasms | Details |
Oberotatug ravtansine | OBT-076; MEN1309/OBT076; MEN-1309 | Phase 1 Clinical | Oxford Biotherapeutics Ltd, Menarini | Solid tumours; Head and Neck Neoplasms; Carcinoma, Adenoid Cystic; Lymphoma, Non-Hodgkin | Details |
This web search service is supported by Google Inc.